US FDA's approval of Boston Scientific Corp.'s Emblem MRI S-ICD subcutaneous implantable defibrillator, announced Aug. 9, is the latest in a string of approvals of ImageReady magnetic resonance imaging-compatible devices that should help the company become more competitive in the cardiac rhythm management market.
Emblem MRI S-ICD, which earned a CE mark in April, is an MR-compatible version of the Emblem S-ICD. (Also see...